An observational study in Noninvavie Ventilation to Patients With COVID-19, sponsored by The First Affiliated Hospital of Guangzhou Medical University. Completed at 1 site in China. Open to participants aged 20 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-09-29.
Sponsored by The First Affiliated Hospital of Guangzhou Medical University · Observational
Noninvasive ventilation(NIV) is an important treatment to the respiratory failure patients.The severe Corona Virus Disease-19(COVID-19) patients are incline to respiratory failure.The NIV may reduce the intubtion rate.This research was taken to investigate the factor to the success of the noninvasive ventilation to the COVID-19 patients with respiratory failure.
Noninvasive ventilation(NIV) is an important treatment to the respiratory failure patients.The severe Corona Virus Disease-19(COVID-19) patients are incline to respiratory failure.The NIV may reduce the intubtion rate.This research was taken to investigate the factor to the success of the noninvasive ventilation to the COVID-19 patients with respiratory failure.We wish to raise the success rate to COVID-19 patients with respiratory failure.More critically ill COVID-19 patients could avoid the intubtion.
7,638 studies on the registry are indexed under COVID-19; 488 are open to participants now.
This study's enrollment of 23 is below the median of 260 across 3,135 observational studies indexed under COVID-19.
Browse COVID-19 studies →The First Affiliated Hospital of Guangzhou Medical University is the lead sponsor of 158 studies on the registry; 65 are open to participants now.
Counted across the registry records on this site, refreshed daily.
respiratory failure patients with COVID-19
Exclusion Criteria:
9）burns, 10) extreme obesity.
Device: noninvasive ventilation
noninvasive ventilation to support the COVID-19 patients with respiratory failure
success rate
the sucess rate of the noninvasive ventilation
Time frame: 4 month
the intubtion rate
the intubtion rate of the COVID-19 patients
Time frame: 4 month
blood lymphocyte
blood lymphocyte of the COVID-19 patients
Time frame: 4month
B-type natriuretic peptide
blood B-type natriuretic peptide of the COVID-19 patients
Time frame: 4 month
Procalcitonin
blood procalcitonin of the COVID-19 patients
Time frame: 4 month
Oxygen Saturation
Oxygen Saturation of the COVID-19 patients
Time frame: 4 month
Plan to share: Undecided — the IPD are going to share after the paper published.
No publications or documents are linked to this record.
This study is completed, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
The First Affiliated Hospital of Guangzhou Medical University